Literature DB >> 8213448

Familial calcification of aorta and calcific aortic valve disease associated with immunologic abnormalities.

C Tentolouris1, T Kontozoglou, P Toutouzas.   

Abstract

We report three patients of the same family with linear calcification of the ascending aorta, severe calcific mixed aortic valve disease associated with increased levels of globulins, lambda-chain gammopathy, an increased T4/T8 lymphocyte ratio, and other immunologic abnormalities. None of the patients had syphilis, atherosclerosis, abnormalities of calcium or phosphorus metabolism, lymphadenopathy, or other systemic diseases. It is postulated that these cases and some previously reported in the literature as idiopathic represent a distinct pathologic entity, familial or sporadic, in which localized vascular and valvular calcific disease is associated with an underlying immunologic disorder or autoimmune process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8213448     DOI: 10.1016/0002-8703(93)90705-e

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  3 in total

1.  Cardiovascular risk factors in patients with aortic stenosis predict prevalence of coronary artery disease but not of aortic stenosis: an angiographic pair matched case-control study.

Authors:  J R Ortlepp; F Schmitz; T Bozoglu; P Hanrath; R Hoffmann
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

Review 2.  Monckeberg's Medial Sclerosis as a Cause for Headache and Facial Pain.

Authors:  Davis C Thomas; Prisly Thomas; Anilkumar Sivan; Priyanka Unnam; Ahana Ajayakumar; Sanjana Santhosh Kumar; Priyanka Kodaganallur Pitchumani; Mahnaz Fatahzadeh; Nida-E-Haque Mahmud
Journal:  Curr Pain Headache Rep       Date:  2021-06-04

3.  APOE alleles are not associated with calcific aortic stenosis.

Authors:  J R Ortlepp; M Pillich; V Mevissen; C Krantz; M Kimmel; R Autschbach; G Langebartels; J Erdmann; R Hoffmann; K Zerres
Journal:  Heart       Date:  2006-04-10       Impact factor: 5.994

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.